ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2618

Bipolar Disorders May Represent a Primary Feature Of Behçet’s Disease

Rosaria Talarico1, Laura Palagini2, Elena Elefante3, Claudia Ferrari4, Chiara Stagnaro3, Chiara Baldini3, Chiari Tani3, Marta Mosca4 and Stefano Bombardieri3, 1Rheumatology Unit, Pisa, Italy, 2University of Pisa, Psychiatry Unit, Department of Neuroscience, Pisa, Italy, 3University of Pisa, Rheumatology Unit, Pisa, Italy, 4Rheumatology Unit, University of Pisa, Pisa, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome

  • Tweet
  • Email
  • Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Frequency of psychiatric disorders in BD is a debated issue: while some experts attribute their presence to the chronicity of the illness, others think that they may be imputable to disease activity or to intrinsic features of the disease. The primary aims were to determine the frequency of psychiatric disorders in BD patients, both with neurological involvement or without; the secondary aims were: to investigate a possible association between disease activity/organ involvement and psychiatric profile of the BD patients and to compare the distribution of psychiatric disorders of patients with BD with those in patients with other chronic diseases.

Methods: One hundred and twenty BD patients with a diagnosis of BD according the ISG criteria were studied. Demographic profile of the cohort studied are summarized in Table 1. Psychiatric disorders evaluated were: bipolar disorder, obsessive-compulsive disorder, depression and sleep disorder. Age and sex matched disease controls of systemic lupus erythematosus (SLE) and chronic arterial hypertension were included. BD disease activity was evaluated by means of BD current activity form 2006 and clinician’s overall perception of disease activity.

Results: Prevalence of psychiatric disorders are shown in Table 2. No correlations were found between the presence of psychiatric disorders and disease activity; specifically either BD patients with an activity index ≤ 7 and ≥ 8 were equally characterized by a high prevalence of psychiatric disorders. Moreover, the occurrence of psychiatric disorders did not result correlating with a specific organ involvement. Comparing the frequency of bipolar disorder with the disease controls, the results have shown a significant difference in favor of bipolar disorder in BD (p < 0.001).

 Table 1. Demographic profile.

 

Neuro- BD

BD without neurological involvement

Number of patients 

46

64

M/F

38/8

42/22

Mean age ± SD (min-max) (years)

43±7 (15-68)

42±8 (18-71)

Mean disease duration ± SD (min-max) (years)

9±2 (3-28)

10±2 (4-28)

Table 2. Prevalence of psychiatric disorders

psychiatric disorders

Neuro- BD

n (%)

BD without neurological involvement

n (%)

bipolar disorder

41 (65)

28 (64)

 obsessive-compulsive disorder

29 (46)

20 (43)

depression

20 (32)

16 (36)

sleep disorder

5 (11)

10 (16)

Conclusion: Our results show a high frequency of psychiatric disorders in BD patients. This elevated prevalence both in BD patient with or without neurological involvement, independently from disease activity and significantly than in disease controls, strongly suggest that psychiatric disorders may represent a primary feature of BD.


Disclosure:

R. Talarico,
None;

L. Palagini,
None;

E. Elefante,
None;

C. Ferrari,
None;

C. Stagnaro,
None;

C. Baldini,
None;

C. Tani,
None;

M. Mosca,
None;

S. Bombardieri,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bipolar-disorders-may-represent-a-primary-feature-of-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology